This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq, Jul 2008]
| OMIM ID: | `OMIM ID 164760
`_ |
Allelic Variants (Selected Examples)
.0001 NOONAN SYNDROME 5
In 7 unrelated patients with Noonan syndrome (NS5; 611553) and 1 patient with LEOPARD syndrome-2 (611554), Pandit et al. (2007) identified heterozygosity for a 770C-T transition in exon 7 of the RAF1 gene, resulting in a ser257-to-leu (S257L) substitution at a conserved residue in the CR2 domain. All patients had hypertrophic cardiomyopathy (CMH), including a 3.6-year-old girl with CMH at birth and a 35-year-old woman with LEOPARD syndrome. Ectopically expressed S257L mutants demonstrated increased kinase activity and enhanced ERK (see 176948) activation.
Razzaque et al. (2007) identified the S257L mutation of the RAF1 gene in 4 unrelated patients with Noonan syndrome, 3 with obstructive and 1 with nonobstructive CMH. The mutation was not found in 100 control individuals or in 100 patients with CMH without Noonan syndrome.
.0002 NOONAN SYNDROME 5
In 5 affected individuals of 2 unrelated families with Noonan syndrome (NS5; 611553), Pandit et al. (2007) identified heterozygosity for a 781C-T transition in exon 7 of the RAF1 gene, resulting in a pro261-to-ser (P261S) substitution at a conserved residue in the CR2 domain. Four of the 5 patients had hypertrophic cardiomyopathy (CMH); the 1 individual with a P261S change but without CMH was a 6-year-old girl whose 38-year-old mother had the same mutation and had been diagnosed with CMH at 23 years of age. The mutation was not found in 210 control individuals.
Razzaque et al. (2007) identified the P261S mutation in 3 Noonan syndrome patients, a 1-year-old boy and his 33-year-old father and an unrelated 16-year-old boy. All 3 displayed CMH. The mutation was not found in 100 control individuals or in 100 individuals with CMH without Noonan syndrome. Transfection studies in HEK293 cells demonstrated that P261S behaved as a gain-of-function mutant with increased kinase and ERK (see 176948) activation compared with wildtype RAF1.
.0003 NOONAN SYNDROME 5
In a sister and brother with Noonan syndrome (NS5; 611553), Pandit et al. (2007) identified heterozygosity for a 1472C-G transversion in exon 14 of the RAF1 gene, resulting in a thr491-to-arg (T491R) substitution in the CR3 domain. Neither sib had hypertrophic cardiomyopathy. The mutation was not found in 210 control individuals.
.0004 LEOPARD SYNDROME 2
In a 43-year-old woman with LEOPARD syndrome-2 (611554), Pandit et al. (2007) identified an 1837C-G transversion in exon 17 of the RAF1 gene, resulting in a leu613-to-val (L613V) substitution at a conserved residue in the C terminus. The patient had hypertrophic cardiomyopathy.
Razzaque et al. (2007) identified the L613V mutation, which they designated as being located in the CR3 domain of RAF1, in 2 unrelated boys with Noonan syndrome (NS5; 611553), neither of whom had hypertrophic cardiomyopathy. The mutation was not found in 100 control individuals or in 100 patients with hypertrophic cardiomyopathy without Noonan syndrome. Transfection studies in HEK293 cells demonstrated that L613V behaved as a gain-of-function mutant with increased kinase and ERK (see 176948) activation compared with wildtype RAF1.
Recent articles:
- Leontovich AA et al. “Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.” Int J Oncol. 2012 Jun;40(6):1858-64. PMID 22447278
- Yosifov DY et al. “Interleukin-6, osteopontin and Raf/MEK/ERK signaling modulate the sensitivity of human myeloma cells to alkylphosphocholines.” Leuk Res. 2012 Jun;36(6):764-72. PMID 22421411
- Stoeckius M et al. “Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin.” J Biol Chem. 2012 May 4;287(19):15418-26. PMID 22262839
- Kuburović V et al. “Two cases of LEOPARD syndrome–RAF1 mutations firstly described in children.” Turk J Pediatr. 2011 Nov-Dec;53(6):687-91. PMID 22389993
- Andersen SD et al. “14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein human exonuclease 1 (hEXO1) via a semi-conserved motif.” DNA Repair (Amst). 2012 Mar 1;11(3):267-77. PMID 22222486
- Tang CH et al. “CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway.” Biochem Pharmacol. 2012 Feb 1;83(3):335-44. PMID 22138288
- Mielgo A et al. “A MEK-independent role for CRAF in mitosis and tumor progression.” Nat Med. 2011 Nov 13;17(12):1641-5. PMID 22081024
- Ye DZ et al. “p21-Activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112.” PLoS One. 2011;6(11):e27637. PMID 22096607
- Ceteci F et al. “Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression.” Neoplasia. 2011 Nov;13(11):1005-18. PMID 22131876
- Hoffmann K et al. “Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.” Anticancer Res. 2011 Nov;31(11):3883-90. PMID 22110214
Top Pubmed articles linked to gene RAF1 matching any search term:
- Kalderon B et al. “Suppression of adipose lipolysis by long-chain fatty acid analogs.” J Lipid Res. 2012 May;53(5):868-78. PMID 22338010
- Ku HC et al. “Green tea (-)-epigallocatechin gallate inhibits IGF-I and IGF-II stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor, but not AMP-activated protein kinase pathway.” Mol Nutr Food Res. 2012 Apr;56(4):580-92. PMID 22495985
- Bonilla AQ et al. “Developmental changes in thermoprotective actions of insulin-like growth factor-1 on the preimplantation bovine embryo.” Mol Cell Endocrinol. 2011 Jan 30;332(1-2):170-9. PMID 20965229
- Okuyama T et al. “The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like signaling in Caenorhabditis elegans.” J Biol Chem. 2010 Sep 24;285(39):30274-81. PMID 20624915
- Sangle GV et al. “Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.” Endocrinology. 2010 Sep;151(9):4455-66. PMID 20630999
- Kawaguchi M et al. “Induction of insulin-like growth factor-I by interleukin-17F in bronchial epithelial cells.” Clin Exp Allergy. 2010 Jul;40(7):1036-43. PMID 20642578
- Xie P et al. “Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.” Am J Physiol Renal Physiol. 2010 Jun;298(6):F1393-404. PMID 20335317
- Park KH et al. “Mechanism of insoluble phosphate solubilization by Pseudomonas fluorescens RAF15 isolated from ginseng rhizosphere and its plant growth-promoting activities.” Lett Appl Microbiol. 2009 Aug;49(2):222-8. PMID 19486289
- Ku HC et al. “Green tea (-)-epigallocatechin gallate inhibits insulin stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway.” Am J Physiol Cell Physiol. 2009 Jul;297(1):C121-32. PMID 19176763
- Padidela R et al. “Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.” Horm Res. 2008;70(3):129-36. PMID 18663312
- MacLaren R et al. “Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue.” J Lipid Res. 2008 Feb;49(2):308-23. PMID 17986714
- Alejandro EU et al. “Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.” J Biol Chem. 2008 Jan 25;283(4):2407-17. PMID 18006502
- Xiang X et al. “Phosphorylation of 338SSYY341 regulates specific interaction between Raf-1 and MEK1.” J Biol Chem. 2002 Nov 22;277(47):44996-5003. PMID 12244094
- Murphy GA et al. “Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.” J Biol Chem. 2002 Mar 22;277(12):9966-75. PMID 11788587
- Zang M et al. “Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1.” J Biol Chem. 2002 Feb 8;277(6):4395-405. PMID 11733498
- Bourbon NA et al. “Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions.” Am J Physiol Cell Physiol. 2001 Jun;280(6):C1403-11. PMID 11350735
- Nantel A et al. “Interaction of the Grb10 adapter protein with the Raf1 and MEK1 kinases.” J Biol Chem. 1998 Apr 24;273(17):10475-84. PMID 9553107
- Luo ZJ et al. “Identification of the 14.3.3 zeta domains important for self-association and Raf binding.” J Biol Chem. 1995 Oct 6;270(40):23681-7. PMID 7559537
- Brtva TR et al. “Two distinct Raf domains mediate interaction with Ras.” J Biol Chem. 1995 Apr 28;270(17):9809-12. PMID 7730360
- Zhang XF et al. “Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.” Nature. 1993 Jul 22;364(6435):308-13. PMID 8332187